TARPLIN, DOWNS & YOUNG, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000.00 income · posted Jul 16, 2026

Lobbying activity 3

Budget/Appropriations

Federal budget issues

Health Issues

Lobbying related to pharmaceutical policy

Medicare/Medicaid

Lobbying related to pharmaceutical and Medicare/Medicaid policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.